Sarantis Group will release its FY 2025 Annual Financial Results and Annual Financial Report, as follows: ▪ Wednesday, March 11 th 2026 following Athens Exchange Market closing – Results and Report Release, which will be available at the Athens Exchange website (https://www.
The company GR. SARANTIS S.A. announces, according to L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, that Mr. Konstantinos Stamatiou, Group Legal Counsel, sold on February 9 th of 2026, 150 common shares at the average price of 14.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on February 3 rd 2026 with the acquisition of 7,403 own shares at the average price of 13.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on February 2 nd 2026 with the acquisition of 8,893 own shares at the average price of 13.
Sarantis Group announces that, following an agreement with Orkla Health AS, it will assume the exclusive distribution of Jordan products in Greek pharmacies as of February 1, 2026. The addition of Jordan to the Group’s portfolio represents a collaboration of strategic importance, further strengthening the Group’s presence in the Greek pharmacy channel and significantly expanding its footprint in the oral hygiene category.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on January 30th 2026 with the acquisition of 7,700 own shares at the average price of 13.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on January 29 th 2026 with the acquisition of 5,000 own shares at the average price of 13.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on January 28 th 2026 with the acquisition of 6,750 own shares at the average price of 13.
Want to learn more about the Group?
Explore our latest news regarding our brands, our activities, our people and our sustainability actions!
SARANTIS Group
26, Amaroussiou - Halandriou Street
151 25 Maroussi, Athens, Greece
Tel: +30 210 6173000
Fax: +30 210 6197081
e-mail: group-info@sarantisgroup.com